Avera Medical Group Chamberlain Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 S Front Street, Chamberlain, SD 57325 Phone: 605-234-6584 Fax: 605-234-5002 |
Access Health Chamberlain Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 101 S Front St Ste 1, Chamberlain, SD 57325 Phone: 605-234-6584 Fax: 605-234-5002 |
Sanford Chamberlain Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-6551 Fax: 605-234-7260 |
Sanford Chamberlain Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 S Byron Blvd, Chamberlain, SD 57325 Phone: 605-234-5511 |
News Archive
BIO-key International, Inc., a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.
Diabetes can result from either a deficiency of insulin or decreased sensitivity to insulin. Researchers at Children's Hospital Boston have discovered a mechanism for normalizing blood sugar that doesn't involve insulin and could offer a new therapeutic approach to both kinds of diabetes.
Times have changed. Within the last ten years, the primary reason that children have had surgery to remove their tonsils and adenoids is not because of infection. Instead, up to 90 percent of the adenotonsillectomy surgeries are to correct obstructive sleep apnea (OSA).
LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.
› Verified 6 days ago